Evidence map›Paper›PMID 42381705›Full record

ArticleMolecular therapy. Nucleic acids2026

Selection and validation of novel DNA aptamer panel co-specific to

Liga Kunrade, Karlis Pleiko, Laura Sproge, Karina Goluba, Teodors Pantelejevs, Nathan Thompson Wright, Inara Akopjana, Janis Bogans, Kaspars Tars, Una Riekstina

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liga KunradeUniversity of Latvia, Faculty of Medicine and Life Sciences, Department of Pharmaceutical Sciences, Jelgavas Street 3, 1004 Riga, Latvia.
Karlis PleikoUniversity of Latvia, Faculty of Medicine and Life Sciences, Department of Pharmaceutical Sciences, Jelgavas Street 3, 1004 Riga, Latvia.
Laura SprogeUniversity of Latvia, Faculty of Medicine and Life Sciences, Department of Pharmaceutical Sciences, Jelgavas Street 3, 1004 Riga, Latvia.
Karina GolubaUniversity of Latvia, Faculty of Medicine and Life Sciences, Department of Pharmaceutical Sciences, Jelgavas Street 3, 1004 Riga, Latvia.
Teodors PantelejevsLatvian Institute of Organic Synthesis, Aizkraukles 21, 1006 Riga, Latvia.
Nathan Thompson WrightJames Madison University, Department of Chemistry and Biochemistry, 901 Carrier Dr, Harrisonburg, VA, USA.
Inara AkopjanaLatvian Biomedical Research and Study Center, Ratsupites 1, 1067 Riga, Latvia.
Janis BogansLatvian Biomedical Research and Study Center, Ratsupites 1, 1067 Riga, Latvia.
Kaspars TarsLatvian Biomedical Research and Study Center, Ratsupites 1, 1067 Riga, Latvia.
Una RiekstinaUniversity of Latvia, Faculty of Medicine and Life Sciences, Department of Pharmaceutical Sciences, Jelgavas Street 3, 1004 Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria remains a major global health concern. The development of point-of-care diagnostic aptasensors could improve malaria detection, patient management, and eradication efforts. We selected and validated single-stranded DNA aptamers against

Indexed as

aptasensorsDNA aptamersmalariaMT: special issue: innovations in aptamer technologyPlasmodium spp.protein SELEX

Identifiers

PMID42381705
PMCPMC13315843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.